Kenyan Healthcare Company Hewatele Secures USD 20 M Funding
- Hewatele has secured a USD 20 million funding package from Finnfund, DFC, SEDF, UBS Optimus Foundation, and Grand Challenges Canada.
- The funds will be used to build a liquid oxygen manufacturing facility in Nairobi and expand distribution capacity in strategic regions of Kenya.
- Hewatele manufactures and distributes medical oxygen through six operational PSA plants in Kenya and Uganda.
The funding secured by Hewatele will enable the company to expand its manufacturing and distribution capabilities, which will contribute to improving access to medical oxygen in Kenya. This investment is crucial, especially in the midst of the COVID-19 pandemic, as medical oxygen is in high demand. It is a positive development for the healthcare sector in Kenya and will have a significant impact on saving lives.
